News | August 21, 2008

St. Jude Medical Gets FDA Approval of Arecibo Manufacturing Plant

August 22, 2008 - St. Jude Medical Inc. this week said the FDA approved of the company’s new facility in Arecibo, Puerto Rico, for the manufacturing of pacemakers and cardiac leads.

The 150,000 square-foot facility, located in Arecibo’s Santana Industrial Park, will initially be used to produce St Jude Medical pacemakers and cardiac leads for domestic and international markets, and the company plans to begin manufacturing implantable cardioverter defibrillators (ICDs) at the facility late this year. The new plant will expand the company’s cardiac rhythm management manufacturing capacity and is expected to create at least 1,250 new jobs within the next three years.

The approval followed a six-month review that included an on-site evaluation by FDA inspectors.

The expansion in Puerto Rico follows other recent expansions at two St. Jude Medical manufacturing facilities in Sylmar, CA., and Liberty, SC, as well as the ongoing expansion at the company’s global headquarters in St. Paul, MN.

In 1987, St. Jude Medical began operations in Puerto Rico with 25 employees at its current Caguas facility. The original 23,000 square-foot plant, which manufactured mechanical heart valves, has evolved with the company’s continuous development of new cardiovascular products, tripling its size and expanding its scope to manufacture more than 220 models of cardiovascular and cardiac rhythm management products that are exported to countries around the world.

The Caguas site will continue to manufacture mechanical heart valves and Angio-Seal vascular closure devices, and also is expected to add new product lines in the future.

For more information: www.sjm.com

Related Content

Medtronic Begins Pilot Study of Investigational Extravascular ICD System
News | Implantable Cardioverter Defibrillator (ICD) | August 09, 2018
Medtronic plc announced the start of a pilot study of its investigational Extravascular Implantable Cardioverter...
ICD Placements Not Meeting Medicare Coverage Criteria Decline After Overuse Investigation Announced
Feature | Implantable Cardioverter Defibrillator (ICD) | July 11, 2018
Placement of implantable cardioverter defibrillators (ICDs) not meeting Centers for Medicare and Medicaid Services (CMS...
New Tool Predicts Benefits and Risks of Implantable Defibrillator for Heart Failure Patients
News | Implantable Cardioverter Defibrillator (ICD) | July 02, 2018
University of Washington (UW) Medicine cardiologists have developed a tool to predict which heart-failure patients...
Real-World Data Demonstrates Success Of Smart Pass Filter on Boston Scientific S-ICD System
News | Implantable Cardioverter Defibrillator (ICD) | May 16, 2018
Boston Scientific announced results from an analysis of the LATITUDE database evaluating the successful reduction of...
Online Message Board Advice on ICDs Reflects Inaccuracies
News | Implantable Cardioverter Defibrillator (ICD) | April 13, 2018
April 13, 2018 — Medical advice about implanted cardiac defibrillators obtained via an online message board appears t
Biotronik U.S. to Distribute Aziyo ECM Envelopes
News | Implantable Cardioverter Defibrillator (ICD) | April 12, 2018
Biotronik U.S. and Aziyo announced a strategic agreement allowing Biotronik to distribute Aziyo's CanGaroo...
Boston Scientific Launches Resonate Devices With HeartLogic Heart Failure Diagnostic
Technology | Implantable Cardioverter Defibrillator (ICD) | September 27, 2017
September 27, 2017 — Boston Scientific recently launched the Resonate family of...
Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD) | September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Predictive Models May Help Determine Which Patients Benefit From ICDs
News | Implantable Cardioverter Defibrillator (ICD) | July 06, 2017
Two predictive models may help cardiologists decide which patients would most benefit from an implantable cardioverter...
Videos | Implantable Cardioverter Defibrillator (ICD) | June 01, 2017
Lucas Boersma, M.D., Ph.D., FESC, St.
Overlay Init